Prevalence and Determinants of Valvulopathy in Patients Treated With Dexfenfluramine

Circulation - United States
doi 10.1161/01.cir.100.21.2161
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Determinants of Heat Generation in Patients Treated With Therapeutic Hypothermia Following Cardiac Arrest

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2014English

Prevalence and Determinants of Glucose Abnormalities Among Patients With Chronic Liver Disease in Alexandria, Egypt

Journal of High Institute of Public Health
2014English

Prevalence of Hyperhomocysteinemia and Its Major Determinants in Rural Chinese Hypertensive Patients

Heart
Cardiovascular MedicineCardiology
2012English

Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated With Sorafenib

Cancer Research
Cancer ResearchOncology
2018English

Prevalence and Factors Associated With Vitamin D Deficiency and Hyperparathyroidism in HIV-Infected Patients Treated in Barcelona

ISRN AIDS
2012English

In Memory of Dexfenfluramine: R.I.P.

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
1997English

Prevalence and Pharmacologic Treatment of Patients With Low Back Pain Treated at Kosovo Energetic Corporation

Medicinski Arhiv
Medicine
2013English

Potentially Inappropriate Medication Use in Older Patients in Swiss Managed Care Plans: Prevalence, Determinants and Association With Hospitalization

PLoS ONE
Multidisciplinary
2014English

Prevalence and Determinants of Unintended Childbirth in Ethiopia

BMC Pregnancy and Childbirth
GynecologyObstetrics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy